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Background: The Core Outcome Measures in Effectiveness Trials (COMET) initiative aims to facilitate the development
and application of ‘core outcome sets’ (COS). A COS is an agreed minimum set of outcomes that should be measured
and reported in all clinical trials of a specific disease or trial population. The overall aim of the Core Outcome
Measurement Instrument Selection (COMIS) project is to develop a guideline on how to select outcome measurement
instruments for outcomes included in a COS. As part of this project, we describe our current efforts to achieve a
consensus on the methods for selecting outcome measurement instruments for outcomes to be included in a COS.
Methods/Design: A Delphi study is being performed by a panel of international experts representing diverse
stakeholders with the intention that this will result in a guideline for outcome measurement instrument selection.
Informed by a literature review, a Delphi questionnaire was developed to identify potentially relevant tasks on
instrument selection. The Delphi study takes place in a series of rounds. In the first round, panelists were asked to rate
the importance of different tasks in the selection of outcome measurement instruments. They were encouraged to
justify their choices and to add other relevant tasks. Consensus was reached if at least 70% of the panelists considered
a task ‘highly recommended’ or ‘desirable’ and if no opposing arguments were provided. These tasks will be included
in the guideline. Tasks that at least 50% of the panelists considered ‘not relevant’ will be excluded from the guideline.
Tasks that were indeterminate will be taken to the second round. All responses of the first round are currently being
aggregated and will be fed back to panelists in the second round. A third round will only be performed if the results of
the second round require it.
Discussion: Since the Delphi method allows a large group of international experts to participate, we consider it to be
the preferred consensus-based method for our study. Based upon this consultation process, a guideline will be
developed on instrument selection for outcomes to be included in a COS.
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There is a lack of consensus with regard to the selection of
outcomes and outcome measurement instruments for clin-
ical trials. This has resulted in different outcomes being
measured and a variety of instruments being used for
measuring the same outcome. This may cause inconsisten-
cies in the outcomes reported and difficulties in comparing
these outcomes in systematic reviews and meta-analyses
[1]. In addition, there is great variability in the quality (for
example, in reliability and validity) of outcome measure-
ment instruments used and it is not always clear if the best
instrument is being used for a given outcome. To over-
come these issues, standardisation of the selection of out-
comes and outcome measurement instruments is needed.
The Core Outcome Measures in Effectiveness Trials
(COMET) initiative, launched in January 2010, aims to
facilitate the development and application of agreed stan-
dardized sets of outcomes, also known as ‘core outcome
sets’ (COS). A COS is an agreed minimum set of out-
comes that should be measured and reported in all clinical
trials of a specific disease or trial population. Although a
COS is disease or population specific, it is not trial spe-
cific; it is a recommendation of what should be measured
and reported in all clinical trials [2]. Initiatives such as
Outcome Measures in Rheumatology (OMERACT), Har-
monizing Outcome Measures for Eczema (HOME), and
TREAT-NMD Neuromuscular Network currently work
on the development and application of agreed standard-
ized sets of outcomes for rheumatic diseases, atopic
dermatitis, and neuromuscular disease respectively. Once
COS are defined, it is then important to achieve consensus
on how these outcomes should be measured.
The Core Outcome Measurement Instrument Selection
(COMIS) project is a joint initiative between COMET and
COnsensus-based Standards for the selection of health
Measurement INstruments (COSMIN). The COSMIN
initiative aims to improve the selection of outcome meas-
urement instruments and, in pursuit of this aim, it has de-
veloped standards for assessing the methodological quality
of studies exploring the measurement properties of out-
come measurement instruments [3]. In addition, COS-
MIN has developed search filters and a protocol for
performing systematic reviews of outcome measurement
instruments [4]. The COMIS project aims to build upon
both the COMET and COSMIN initiatives with the ultim-
ate aim of developing a guideline on how to select
outcome measurement instruments for outcomes to be
included in a COS. It is expected that such a guideline will
support COS developers in the task of selecting outcome
measurement instruments, thereby meeting the agreed
standards for each of the outcomes included in a COS.
When selecting outcome measurement instruments, a
number of aspects need to be considered a priori, such as
the construct(s) to be measured, the target population,and the goals of treatment. In addition to this, a number
of tasks need to be performed, for example a literature
search to find potentially relevant outcome measurement
instruments for a particular outcome, and a quality assess-
ment of the available instruments.
Currently, no guidelines are available to support out-
come measurement instrument selection. The aim of the
present study is to achieve consensus on the methods for
selecting outcome measurement instruments for outcomes
to be included in a COS. If there is an absence of empirical
evidence to inform such a consensus then different
methods can be used to synthesize the opinions of experts
based on their expertise and scientific background. These
methods are increasingly being used to develop guidelines
that are used in healthcare [5]. Three main approaches
exist: the Delphi method, the nominal group technique
(also known as expert panel), and the consensus develop-
ment conference [6]. All three methods involve reaching
consensus. However, in a Delphi study the group does not
need to meet, which confers anonymity, and opinions are
to be expressed free from group pressure. This is our
rationale for undertaking a Delphi study. The results of the
Delphi study will be used to inform the content of the
guideline on how to select outcome measurement instru-
ments for outcomes included in a COS. In addition to the
results of the Delphi study, input from other resources will
also be used, such as from COSMIN and the Primary
Outcomes Reporting in Trials (PORTal) initiative which
examines the reporting and validation of outcome meas-
urement instruments in clinical trials [7].
We believe that an agreed guideline on outcome meas-
urement instrument selection will promote and supple-
ment the development and use of COS with the advantage
of improving the standard of all clinical trials.
Methods/Design
Delphi method
A Delphi study, informed by a literature review, is being
performed aiming to achieve consensus on relevant tasks
that need to be performed when selecting instruments
for outcomes to be included in a COS (Figure 1).
Literature review
A literature review was performed to identify existing
studies that provide relevant information on the develop-
ment of guidance on outcome measurement instrument
selection. This literature review also helped us by identify-
ing relevant stakeholders and international experts that
were invited to participate in the Delphi study.
Eligibility criteria
The following types of studies were included: guidelines,
reviews, systematic reviews, meta-analyses, and protocols
that develop or apply methodology for selecting outcomes
Definition of the research objective
Selection of experts
To achieve consensus on how to select 
outcome measurement instruments for 
outcomes included in a COS
A ‘snowball sampling’ approach will be used 
to select panelists
First round
Rating the importance on each question            
in the questionnaire
Questionnaires will be emailed to all     
panelists who will be asked to rate the 
importance on given questions on 
potentially relevant tasks in selecting 
outcome measurement instruments for COS
Second round
Re-rating of questions on which no 
consensus was achieved in the first round
Analysis 
Results of the re-ratings will be analyzed for 
agreement and consensus
Panelists will be asked to review their initial 
responses in view of the groups’ response 
on tasks were no consensus was achieved 
in the first round
If consensus is being achieved, the process 
may cease; in case of disagreement the 
second round will be repeated (third round)
Results
Literature review
Development of the Delphi
questionnaire
To identify potentially relevant tasks that 
could be included in the guideline on 
instrument selection for COS
Based on findings in the literature questions 
will be formulated
The identified tasks will ultimately be 
included in a guideline on outcome 
measurement instrument selection for 
outcomes included in a COS
Third round
Analysis Results of the ratings will be analyzed for 
agreement and consensus
Figure 1 Overview of the Delphi method.
Prinsen et al. Trials 2014, 15:247 Page 3 of 7
http://www.trialsjournal.com/content/15/1/247or outcome measurement instruments to be used in clin-
ical trials. Studies that discuss how to measure rather than
how to select outcomes or outcome measurement instru-
ments for use in clinical trials were excluded. Studies that
mainly discussed performance characteristics of outcome
measurement instruments were excluded as well.
Literature search
An electronic literature search was conducted by a re-
search librarian (SKJ) to identify studies that provide rele-
vant information on instrument selection. The search
strategy was developed by consulting search strategies
outlined by Reeve et al. who performed a study on the de-
velopment of minimum standards for patient-reported
outcome measures [8], Terwee et al. who developed a
methodological PubMed search filter for finding studies
on measurement properties of outcome measurement
instruments [4], Sinha et al. who performed a systematic
review of studies that address the selection of outcomes to
measure in clinical trials in children [9], Brettle et al. whoperformed a study about searching for information in
MEDLINE efficiently and effectively [10], and by search
terms gathered from the online MEDLINE thesaurus and
medical subject headings (MeSH). The search was limited
to English language articles and humans, and there were
no restrictions for publication dates. Searches were per-
formed in the following databases: MEDLINE, CINAHL,
Embase, and PsycINFO. Our search strategy is presented
in full in Table 1.
Selection of articles
An initial selection of articles was performed by a research
librarian (SKJ), who excluded references that were not
guidelines, reviews, systematic reviews, meta-analyses, or
protocols. Two reviewers (SI and ZB) selected articles
based on titles and abstracts that were identified from the
literature searches, taking the predefined inclusion criteria
into account. Differences in selection were discussed and,
based on consensus by the two reviewers, a decision was
made whether the article fulfilled the eligibility criteria. In
Table 1 Search strategy
Search terms
1. “Outcome Assessment (Health Care)”/
2. Clinical Trials as Topic/
3. guidance.ti,kw.
4. guideline*.ti,kw.





10. (outcome* adj2 instrument*).ti,kw.
11. measurement instrument*.ti,kw.
12. 1 or 2
13. 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
14. 12 and 13
15. limit 14 to (guideline or meta analysis or “review”)
16. limit 15 to English language
17. limit 16 to humans
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independent reviewer (SV) was consulted.
Development of the Delphi questionnaire
From the literature review potentially relevant tasks on in-
strument selection were identified and included in the
Delphi questionnaire. These tasks consist of, but are not
limited to: (1) conceptual considerations, for example a
description of the construct(s) to be measured, the meas-
urement aim (a discriminative, predictive, or evaluative
purpose), and the target population for which the instru-
ment is intended; (2) methods of finding relevant outcome
measurement instruments, for example by using existing
systematic reviews of instruments on a specific construct
or, in the absence of an existing systematic review, by
performing a systematic review of instruments, by using
existing databases of instruments, or by performing
(additional) literature searches; (3) methods of evaluating
outcome measurement instruments, for example by de-
scribing and comparing the qualitative attributes (number
of items, response categories, and so forth), content, and
measurement properties of the instruments, and consider-
ing the feasibility of the application of the instrument; (4)
methods for applying quality criteria for good outcome
measurement instruments, for example minimal criteria for
good measurement properties or minimal standards for
selecting an instrument; (5) performing validation studies if
necessary; and (6) methods for selecting the most appro-
priate instrument for each outcome included in a COS.
Questions were formulated on the relevance of each of
the tasks to be included in the Delphi questionnaire.Definitions
Similar constructs are defined differently across several re-
search groups such as COMET, OMERACT, and HOME.
As there is currently no consensus on the definitions, we
would like to explicitly state the definitions that are being
used in the COMET Delphi study in order to avoid any
possible misinterpretations.
Core outcome set (COS)
A COS is an agreed minimum set of outcomes that should
be measured and reported in all clinical trials of a specific
disease or trial population. A COS includes all relevant
outcomes of a specific health condition within a specified
setting (the OMERACT definition refers to ‘core domain
set’ whereas the HOME definition refers to ‘core outcome
domains’).
Outcome
An outcome refers to what is being measured, also re-
ferred to as a concept, construct, or (sub)domain. In the
context of a clinical trial it refers to any identified result in
an outcome arising from exposure to a causal factor or a
health intervention (the OMERACT definition refers to
‘(sub)domain’ whereas the HOME definition refers to ‘out-
come domain’).
Outcome measurement instrument
An outcome measurement instrument refers to how the
outcome is being measured (the tool used to assess the
outcome). An outcome measurement instrument can be a
single question, a questionnaire, a performance-based test,
a physical examination, a laboratory measurement, an im-
aging technique, and so forth (the HOME definition refers
to ‘outcome measure’).
Outcome parameter
An outcome parameter refers to any identified result in an
outcome arising from exposure to a causal factor or a
health intervention (the OMERACT definition refers to
‘outcome’).
The terms and definitions of measurement properties
will be adopted from COSMIN [11].
Selection of experts
The selection of panelists should reflect the population
that is intended to use the guideline for instrument se-
lection. In order to enhance the credibility and accept-
ance of the guideline, the panelists should be selected
from a diverse range of institutions and organizations
that may facilitate the dissemination and implementation
of the guideline for instrument selection [5].
A ‘snowball sampling’ approach was used to select pan-
elists for the Delphi study. The identification of relevant
stakeholders and experts began with a preliminary list of
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credibility relating to the target audience as indicated by,
for example, authorship of multiple frequently cited publi-
cations in this field). These experts were selected from the
following institutions and/or working groups: Cochrane Pa-
tient Reported Outcomes (PRO) Methods Group; COMET
initiative, COSMIN Delphi panel and Steering Committee;
Equator Network; HOME initiative; Idea, Development,
Exploration, Assessment, Long-term follow-up (IDEAL)
collaboration; International Spinal Cord Society; Inter-
national Society for Quality of Life Research (ISOQOL);
North West Hub for Trials Methodology Research;
OMERACT initiative; PORTal initiative; Standard Protocol
Items: Recommendations for Interventional Trials (SPIRIT)
group; Standards for Research in Child Health (StaR Child
Health) Steering Group; and TREAT NMD alliance. In
addition, editors of important relevant journals, such as
Quality of Life Research and the Journal of Clinical
Epidemiology, were invited to participate as well. The pre-
liminary list was then augmented with authors who have
published in relevant topics, mostly informed by the litera-
ture search. Finally, stakeholders and experts were given
the opportunity to add whomever else they felt should be
included as a relevant stakeholder. To facilitate the dissem-
ination and implementation of the final guideline we intend
to be inclusive of relevant stakeholders and/or perspectives.
We found no guidelines for the sample sizes of Delphi
studies but in general, having more panelists will increase
the reliability of group judgment [5]. In the COSMIN Del-
phi study, 70% of the invited experts agreed to participate
[3,12], but as the topic of the present study is much broader
we anticipated a lower response rate (between 30 and 40%).
We therefore invited all 481 experts identified in the
methods outlined above to participate in this Delphi study.
First round
The Delphi method involves in a series of rounds in
order to achieve consensus among a panel of experts [6].
In the first round, a link to the electronic version of the
Delphi questionnaire, including instructions for comple-
tion, was sent by email to 120 panelists (24.9%) who
accepted our invitation to participate. In the first round,
panelists were asked to anonymously rate the relevance of
different tasks of three main themes on outcome measure-
ment instrument selection. They were asked to rate the
importance of conceptual considerations, the relevance of
different tasks in finding instruments, and the required
evidence and minimal standards for measurement proper-
ties of instruments to be included in a COS. Responses
could be given on a multiple response scale, for example
‘highly recommended’, ‘desirable’, ‘not relevant’, or ‘not my
expertise’. Examples of questions on the conceptual con-
siderations in the selection of outcome measurement in-
struments include: ‘Should COS developers agree in detailupon the constructs to be measured before starting to
search for outcome measurement instruments?’; ‘Should
COS developers agree upon the target population before
starting to search for outcome measurement instruments?’;
and ‘Should COS developers agree for each outcome upon
the type of instrument to be used before starting to search
for outcome measurement instruments?’. Examples of
questions on finding relevant outcome measurement
instruments include: ‘Should COS developers search for
existing systematic reviews of outcome measurement
instruments?’ and ‘Should COS developers search in
electronic literature databases (for example PubMed or
Embase) to find relevant outcome measurement instru-
ments?’. Examples of questions on the evaluation of
outcome measurement instruments include: ‘Should evi-
dence be available on the internal consistency of outcome
measurement instruments to be included in a COS?’ and
‘What should be the minimum standard for internal
consistency for an outcome measurement instrument to be
included in a COS?’.
Panelists were encouraged to justify their choices in free
text boxes, which could be supported by relevant litera-
ture, and to add other possibly relevant tasks. Subse-
quently, panelists were asked for their opinion on whether
the methods for selecting outcome measurement instru-
ments for a COS are similar to the methods for selecting
outcome measurement instruments for individual clinical
trials. This question was to determine whether panelists
felt that the same guidelines could be applied to an indi-
vidual clinical trial. Panelists were asked to respond within
three weeks. To increase the response rate, an email
reminder was sent after two weeks.
A total of 95 panelists (79.2%) completed the first ques-
tionnaire, representing 14 countries. Most of the panelists
came from the Netherlands (N = 19), Australia (N = 15),
Canada (N = 14), and the UK (N = 12). Brazil, Norway,
Portugal, and Switzerland were represented by one panel-
ist each. Of the panelists, 42.1% were epidemiologists,
31.6% were allied healthcare professionals, 30.5% were
clinimetricians or psychometricians, 29.5% were medical
doctors, and 10.5% were statisticians. A total of 15.8% in-
dicated that they had another academic background. The
current professions of the panelists included researchers
(92.6%), clinicians (27.4%), and journal editors (9.5%).
Thirty panelists (31.6%) indicated that they had ‘no experi-
ence’ in COS development, 28 panelists (29.5%) indicated
to have ‘some experience’, 26 (27.4%) had ‘a little experi-
ence’, and 11 (11.6%) had ‘a lot of experience’.
Second round
The responses of this panel are currently being aggregated
and will be fed back to all panelists anonymously in a
feedback report as part of the second round. In the second
round, panelists will be asked to review their initial
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first round in the light of the groups’ responses.
Analysis
We define consensus on a task to have been reached when
at least 70% of the panelists considered the task ‘highly
recommended’ or ‘desirable’ and if no opposing argu-
ments are provided. Tasks on which such consensus is
reached will be included in the guideline and panelists will
not be asked to vote for these tasks again. When at least
50% of the panelists consider a task ‘not relevant’ and
when no strong arguments in favor of this task are given,
we plan to exclude the task from the guideline. Tasks
which attract an indeterminate response will be taken to
the second round of this Delphi consultation [6,13].
Based on the responses given in the first round, includ-
ing the comments given in the free text boxes, proposals
will be formulated. Panelists will be asked to rate their
agreement on the given proposals. Response options will
include ‘strongly agree’, ‘agree’, ‘no opinion’, ‘disagree’, and
‘strongly disagree’. Additionally, new questions that may
arise based on the comments given, will be formulated.
These questions will be marked as ‘new questions’ and
panelists will be asked to rate the relevance of these tasks
in the second round. The results of the second round will
then again be analysed for consensus following the same
procedure as for the first round.
Third round
Tasks from the second round that remains indeterminate
will be taken to the third round. In the third round, the re-
sults from the second round will again be fed back to all
panelists anonymously in a feedback report and panelists
will again be asked to re-rate the indeterminate tasks in
view of the groups’ response. For tasks that come back as
contentious even after round three, the COMIS Steering
Committee (CP, CT, MR, and SV) will plan a face-to-face
meeting to discuss these tasks. A third round will be omit-
ted if the results of the second round suggest that consen-
sus is being obtained following our predefined consensus
criteria.
Results
Results will be anonymously reported in a consensus
report which will be distributed among all panelists who
participated in the Delphi study. This report will include
an indication of the distribution of panelists’ ratings,
including their comments and suggestions. Results will
be presented both quantitatively (median scores and the
interquartile ranges) and qualitatively (listings of the
comments and suggestions given by the panelists). The
identified tasks will ultimately be included in a guideline
on outcome measurement instrument selection for out-
comes to be included in a COS.Ethics
As this project does not involve patients or study subjects,
according to the Dutch Medical Research in Human
Subjects Act (WMO) it is exempt from ethical approval in
The Netherlands. No ethical approval is required in the
UK for identical reasons. Ethical approval has been
obtained from the ethical committee of the University of
Alberta, Canada.
Discussion
When insufficient or contradictory information is avail-
able on a certain topic, consensus-based methods such as
a Delphi method are generally considered to be appropri-
ate methods to determine the extent to which experts
agree on that topic. Since the Delphi method allows a
large group of international experts to participate, we con-
sider it to be the preferred method for our study. A Delphi
method is relatively less expensive and overcomes some of
the disadvantages, or limitations, that are generally found
with decision-making processes in groups or committees.
Performing an anonymous Delphi study by email may
avoid dominance of certain persons in face-to-face group
meetings. Secondly, feedback is provided in a controlled
manner [14,15]. The results of a Delphi study are highly
dependent upon the composition of the panel. Therefore,
we aimed to include a sample of experts in the field who
represent diverse institutes and organizations and reflect
the population that is intended to use a guideline for out-
come measurement instrument selection. However, it is
difficult to examine the representativeness of the panelists
as it is impossible to draw a random sample from all ex-
perts. Experts were therefore selected non-systematically
which may be considered as a limitation of our study.
The ultimate aim of the COMIS project is to support
COS developers on how outcomes included in COS
should be defined and measured by providing a guideline
on outcome measurement instrument selection. To this
aim, eight different tasks are currently being executed, of
which the Delphi study is one of them. The specific objec-
tives of these tasks are: (1) to identify existing research
and relevant partners in the field of instrument selection;
(2) to provide guidance and support to COS developers
on how to find all measurement instruments that measure
a specific core outcome; (3) to identify the essential infor-
mation that should be gathered for each measurement
instrument identified, including characteristics of the
instrument and information on measurement properties;
(4) to collect available systematic reviews of measurement
instruments; (5) to provide guidance and support to COS
developers on how to perform systematic reviews of meas-
urement instruments; (6) to provide guidance and support
to COS developers on selecting instruments for COS; (7)
to disseminate findings on measurement instruments
among COS developers; and (8) to develop a workshop on
Prinsen et al. Trials 2014, 15:247 Page 7 of 7
http://www.trialsjournal.com/content/15/1/247evidence-based instrument selection for COS developers.
The results of each task will be used as input for the final
guideline on outcome measurement instrument selection
for outcomes to be included in COS. The guideline will
promote the development and use of COS, which will ul-
timately improve the conducting and reporting of clinical
trials and enhance the value of evidence synthesis by redu-
cing heterogeneity between trials.
Trial status
The Delphi study is currently ongoing. It is anticipated
that the second Delphi questionnaire will be sent to all
panelists who agreed to participate in the second round in
May 2014. A published guideline on the methods for
selecting outcome measurement instruments to be in-
cluded in a COS is expected by the end of 2014.
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